Literature DB >> 1576172

Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma.

P Allain1, S Berre, Y Mauras, A Le Bouil.   

Abstract

Among the different analytical methods used for the determination of platinum in blood plasma from patients treated by platinum derivatives, inductively coupled plasma mass spectrometry appears to be the most sensitive (detection limit 0.05 microgram l-1) and the best adapted for measuring low concentrations. The preparation of the samples consisted only of a dilution. The recoveries were close to 100% and both within-run and between-days reproducibility were very good. The determination of free platinum which was only about 5% of total plasma platinum was chosen to illustrate the inductively coupled mass spectrometric method.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576172     DOI: 10.1002/bms.1200210305

Source DB:  PubMed          Journal:  Biol Mass Spectrom        ISSN: 1052-9306


  2 in total

Review 1.  Oxaliplatin: pharmacokinetics and chronopharmacological aspects.

Authors:  F Lévi; G Metzger; C Massari; G Milano
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

2.  Long-term pharmacokinetic behavior of platinum after cisplatin administration.

Authors:  E Gamelin; P Allain; P Maillart; A Turcant; R Delva; A Lortholary; F Larra
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.